Background: Angiotensin converting enzyme (ACE) inhibitors are used widely in the treatment of hypertension and heart failure. These inhibitors such as captopril and enalapril are derived from natural products.
Implication for health policy/practice/research/medical education:
Introducig of new antihypertensive medications.
tensin I, which, in turn, generates a potent vasopressor octapeptide, angiotensin II. ACE is also involved in the degradation of vasodilator bradikinin (2) . Most if not all commercialized ACE inhibitors have utilized peptides from the venom of the Brazilian viper Bothrops Jararaca as model substances (3) . Besides this animal source, microorganisms and plants deliver compounds with ACE inhibitory activity which could serve as model substances in the development of new ACE inhibitors. ACE inhibitors prevent the formation of angiotensin II by ACE and thereby reduce peripheral vascular resistance and blood pressure. However, these synthetic drugs are believed to have certain side effects such as cough, taste disturbances and skin rashes (4) . Therefore, for safe and economical use, interest in identifying food sources as ACE inhibitor has increased. More potent ACE inhibitors have also been designed and synthesized to treat hypertension effectively. Oral administration of these drugs frequently results in unwanted side effects; a nutritional approach might be a better medium by which blood pressure in controlled.
Screening for antihypertensive effects in traditional medicines has been performed over many years and certain animal models have been utilized (5) . In western medicine, drug development has become increasingly more mechanistic in the focus of excluding unwanted side-effects (5) . The rationale behind this approach is to identify a molecular target (receptor or enzyme) which has an essential role both in the regulation of the disease and the search for ligands, substrates or inhibitors of the target. In the treatment of hypertension, inhibition of the ACE is established as one the current therapeutic principles. (6) In Persian the different traditional medicine systems make use of a number of plants for treating of the hypertension. In order to evaluate the biological activity of Persian medicinal plants, this study was conducted to evaluate the antihypertensive activity of some of these plants based on an in vitro bioassay for ACE inhibition. A number of screening studies have been made on the ACE inhibitory activities of higher plants and different screening methods have been used. To researchers, a variety of methods (e.g. spectrophotometry and fluorometry) are available by which ACE activity can be detected and analyzed (7, 8) . High performance liquid chromatography (HPLC) is widely used because of its effective separation of the substrate and product from the ACE reaction mixture in order to ensure accurate measurements. (1995) reported the result of screening of 31 species from India, China & Chile in which all of them used HPLC assay method for these screening. Arisawa et al. (1985) investigated some 38 samples of crude drugs by means of spectrophotometric & fluorimetric assay (14) ; Yun et al. (1981) investigated 27 plant species used to treat hypertension in Korean folk medicine (15) .
Furthermore, some studies have been made on single plant species where several classes of ACE inhibitory compounds have been identified, for example proanthocyanidins (16) (17) (18) , flavonoids (18, 19) , xanthones (20) , peptides (17) , and secoiridoids (21) for a comprehensive review of these compounds (22) .
To authors' knowledge and research in relevant literature, no documents have been reported in Traditional Persian Medicine regarding the systematically screening for this target. Thus, the present study may represent an opportunity to find new non-chemical agents to develop new antihypertensive drugs.
Materials and Methods

Plants Material
In this study 135 plants used in Traditional Persian Medicine have been investigated for their ACE inhibitory activity. They were selected on the basis of their usage as antihypertensive, cardio-tonics, and diuretics. 
Preparation of Crude Extracts
All plant materials were air dried in the shade before extraction. After grinding, a 1g weight of the dried plant material was extracted with 10 ml water or ethanol (96%) respectively for 2 hours in an ultrasonic bath. The extract were filtered and concentrated in vacuum except for the water extracts, which were freeze-dried. Then the extracts were kept at 2-6°C (refrigerator).
Chemicals and Buffers
Hippuryl-L-Histidyl-L-Leucine (HHL) and hipuric acid (HA), were purchased from Sigma; all other reagents were analytical grade. 1) Assay buffer: HEPES-NaOH, 50mM, and pH 8.0 contain 300mM NaCL (11.92g of HEPES and 17.52g of NaCL are dissolved in 900 ml bidistilled water, adjusted to pH 8.0 with NaOH and diluted to liter). Before use, buffer is filtered using a filter with a pore diameter of 0.45µm.
2) Substrate (3.5 mM): 5.2 mg of HHL (Hippuryl-L-Histidyl-L-Leucine) are solved in 1ml assay buffer. This solution should be prepared freshly before each assay.
3) Stop solution (0.1N): 11.92g of HPES are dissolved in 800 ml bidistilled water, adjusted to pH 9.0 with NaOH 1 M and diluted to liter). Before use, solution is filtered us-ing a filter with a pore diameter of 0.45µm.
Enzyme
For these studies, a commercially available angiotensin-converting-enzyme preparation from rabbit lung (EC 3.4.15.1-purchased from sigma) has been used.1 unit angiotensin-converting enzyme with the specific activity of 3 units/mg protein is dissolved in 2500µL assay buffer. The enzyme solution is highly active and stable for at least 3 months at 2-6°C (refrigerator).
Preparation of Crude Extracts
Solutions of inhibitors are made by dissolving 1mg of test compound in 1mL of buffer which may contain up to 10% of an organic solvent such as ethanol. This corresponds to a final concentration of 0.33 mg test compound in 1mL assay volume.
ACE-assay
ACE activity was assayed according to the method described by Horiuchi et al. (1982) and modified by Schnaith et al. (1994) (23, 24) with some modifications for micro assay. This method is based on the ACE-catalyzed cleavage of the HHL (Hippuryl-L-Histidyl-L-Leucine), into Hippuric acid, which is quantitatively measured by High Performance Liquid Chromatography (HPLC). The reaction can be represented as shown in Figure 1 . 25 µL of inhibitor solution or assay buffer (for control incubation) are placed into a micro tube and mixed with 25 µL enzyme solution. The micro-tube is placed for 5 min in a thermo-mixer at 37°C and the reaction is started by the addition of 25 µL substrate solution (3.5Mm).After incubation at 37°C, the enzyme reaction is stopped by the addition of 50 µL 0.1N Na2EDTA. The incubation time depends on the activation of the applied enzyme batch. No internal standard was used in this procedure. The incubation mixtures are transferred to HPLC tubes. Assays were performed in duplicate. A blank assay was performed for each extracts tested. (Figure 2) 
High Performance Liquid Chromatography (HPLC)
The product (HA) and unreacted substrate (HHL) are separated and quantified by reversed phase HPLC with UV detection at 228nm. (1) Using this gradient elution system, the total separation is achieved within 5 min.
Quantitative Analysis
It was established that the percentage conversion of the substrate by the enzyme was an accurate method to determine the percentage inhibition of the samples. The following formula was used to calculate the percentage of enzyme activity. This method assumed that the control (without the presence of any inhibitors) would have the highest percentage of the ACE activity. A sample exhibiting high inhibition levels would have low percentage of the ACE activity.Using the following equation, the percentage inhibition of the sample could be calculated: Inhibition (%) = 100-Activity (%)
Tannins Tes
The tannins test was performed by extracting 5g of dry plant material with 50 mL of water or ethanol (96%). After evaporation of the solvents, the extracts were re-dissolved in 13 mL hot water (90-100°C) and allowed to cool to the room temperature. Two drops of 10% NaCL were added to 'salt' out any non-tannin compounds which could cause a false positive reaction. After vacuum filtration, 3 mL of the filtrate was added to each of four test tubes. The following solutions were added to the test tubes:
1. 4-5 drops of 1% gelatin solution, 2. 4-5 drops of 1% gelatin + 10% NaCL solution, 3. 3-4 drops of 10% ferric chloride, 4. Control (no solution added). The first and second tubes were observed for the formation of precipitate and the third tube was observed for color produced.
The test would be considered negative if test tubes 1 and 2 showed no precipitation or if 3 showed no color formation, and positive if test tubes 1 and 2 showed precipitation and 3 shows color formation (either blue-black for hydrolysable or brownish-green for condensed tannins) (12).
Statistical Analysis
For statistical analysis ANOVA (Analysis of variance) and t-test in SPSS ver.11 software were used to determine significant differences between groups and P < 0.05 were considered significant. (Figure 3) 
Results
Hippuric acid Standard Curve
Linearity of Enzyme Reaction
The time course action of the enzyme was determined by reacting HHL at a concentration of 3.5mM with 1 units of ACE enzyme at varying incubation times. By plotting the percentage of product (HA) against time, it was possible to determine over what time period the enzymatic activity was constant. Figure 4 shows that the enzymatic rate was constant over a period of 35 min which it would indicate the optimum incubation time from the bioassay.
Establishing the Sensitivity of the ASssay System
The sensitivity of the assay was tested by determination of the IC50 value of the competitive inhibitor captopril and comparing the value cited in the literature ( Figure  5) .The values in the literature were similar to the one determined in this study. From the data, the IC50 value of 20 nM was established. The reference value in the literature for captopril is 23 nM (25).
ACE Inhibitory Activity of Medicinal Plants
The results of the screening are presented in Table 1 . In total, 52 Species out of 135 (39%) are screened, have resulted in an ACE inhibition around or above 50%, redering them suitable for closer investigation and isolation of active constituents. these species are further screened for their content of tannins and results are summarized in Table 1 . In total, 40 species (29% of total investigated) have been found to possess a high ACE inhibiting ability, not depending on the presence of tannins.
Discussion
To obtain the active substances for ACE inhibition the screening was performed on 135 species which were selected on the basis of their usage as antihypertensive, cardio-tonics & diuretics, using water and ethanol (96%) extraction.
As far as possible, the traditionally used part of the plant was employed for the screening. However, in certain cases other parts were also tested. A literature survey on pharmacological activity of all the plants screened for ACE inhibitory activity was carried out and summarized in This study showed that the water extract didn't give the same result as ethanol extract in each spices and this two groups showed significant differences, like the study of Adseren et al. (1997) (13) . On the other hand, this is of considerable magnitude, no less when it is taken into account that the alleged effects are not necessarily medicated by ACE inhibition. We have found a rather high positive hit rate (29%) among this figure which is based on crude extracts and inhibits the enzyme by more than 50% when there is 0.33 mg test compound in 1 ml assay volume, as described by Elbi and Wagner (1991) (17) . However, the limit of 50% is a hypothetical value which is difficult to justify since we do not know anything about the compounds present in the crude extracts.
Several crude extracts in the present investigation have given an inhibition in the interval from 35 to 50% and should thus be regarded as negative. Our suggestion is that sample with an inhibition in this interval could well be worth a reinvestigation but this should be based upon a new collection of the plant material.
In some cases, identical plant materials were collected in different localities which also resulted in differences in ACE inhibition (Hibiscus gossypifolius Mill.). Nyman et al. (1998) reached the same conclusion (12); these contradictory results probably arise from differences in the ages of the plants specimens assayed and/or from variations in environmental conditions.
The presence of a strong ACE inhibitory activity, however, does not necessarily imply that the species could provide powerful antihypertensive drugs. As discussed by Wagner et al. (1991) (17) , some flavonoids may show an in vitro activity due to the generation of chelate complexes within the active center of ACE. It must be remembered that if the plant exhibits low levels of ACE inhibitory activity, it may act on a different mechanism causing hypertension; as a result, it could be used as an antihypertensive agent.
In conclusion, the screening report in this paper has led to the identification of two species from the Persian flora with high potential antihypertensive activity by inhibition more than that of 80% of ACE activity: Peganum harmala L. and Berberis integrrima Bge. Berberis integrrima Bge is used traditionally in Persian as antihypertensive and, then, our results corroborated its popular use.
Further studies on the pure compounds isolated from the active extracts are necessary, and work in this area is presently going on in our laboratory.
Due to the abundant of plants in Persian, there lies an untapped reservoir of potentially useful chemical compounds; unique templates that could serve as the starting points for analog preparation by chemist, as well as interesting tools that can be applied to achieve a better understanding of biological processes involved in hypertension.
